英文報告（１）英文原著
No. Author

Title

JournalVol. Page

1

Aizawa N, Homma Y, Igawa Y

Effects of L-arginine, mirabegron, and oxybutynin on the primarybladder afferent nerve activities synchronized with reflexic,
Neurourol Urodyn 34
rhythmic bladder contractions in the rat

2

Aizawa N, Ito H, Sugiyama R, Fujimura T, Suzuki M,Fukuhara H, Homma Y, Igawa Y

Selective inhibitory effect of imidafenacin and 5-hydroxymethyl
tolterodine on capsaicin sensitive C fibers of the primary bladdermechanosensitive afferent nerves in the ratJ Urol

3

Aizawa N, Ogawa S, Sugiyama R, Homma Y, Igawa Y

Influence of urethane-anesthesia on the effect of resiniferatoxin
treatment on bladder function in rats with spinal cord injury

Neurourol Urodyn 34

274-92015

4

Aizawa N, Wakamatsu D, Kida J, Otsuki T, Saito Y,Matsuya H, Homma Y, Igawa Y

Inhibitory effects of retigabine, a Kv7 channel activator, on
mechanosensitive primary bladder afferent activities andnociceptive behaviors in rats

Neurourol UrodynEpub2015

5

Aizawa N, Ito H, Sugiyama R, Fujimura T, Fukuhara H,Kume H, Homma Y, Igawa Y.

Effects of Sildenafil, a phosphodiesterase type 5 inhibitor, on theprimary single afferent activity of the rat bladder.

LUTSEpub2015

6Akiyama Y, Nomiya A, Niimi A, Yamada Y, Fujimura T,Nakagawa T, Fukuhara H, Kume H, Igawa Y, Homma Y

Botulinum toxin type A injection for refractory interstitial cystitis:
A randomized comparative study and predictors of treatment
Int J Urolresponse

22835-41

2015

7Elucidation of the molecular mechanisms underlying adverseAmemiya T, Honma M, Kariya Y, Ghosh S, Kitano H,
reactions associated with a kinase inhibitor using systems
Kurachi Y, Fujita K-i, Sasaki Y, Homma Y, Abernethy D R
toxicology.

Systems Biology
1and Applications

15005

2015

368-74

Year2015

193 1423-32 2015

8Azuma T, Nagase Y, Oshi M

Pyuria predicts poor prognosis in patients with non-muscleinvasive bladder cancer treated with bacillus Calmette-Guérin.

Mol Clin Oncol

9Fujimura T, Menon M, Fukuhara H, Kume H, Suzuki M,Yamada Y, Niimi A, Nakagawa T, Igawa Y, Homma Y

Validation of an educational program balancing surgeon training
and surgical quality control during robot-assisted radical
prostatectomy

Int J UrolFujimura T, Takahashi S, Kume H, Urano T, Takayama K,
10 Yamada Y, Suzuki M, Fukuhara H, Nakagawa T, Inoue S,Homma Y

11Fujimura T, Yamada Y, Sugihara T, Azuma T, Suzuki M,Fukuhara H, Nakagawa T, Kume H, Igawa Y, Homma Y

311131116

2015Epub2015

2015

Toremifene, a selective estrogen receptor modulator, significantly
improved biochemical recurrence in bone metastatic prostate
BMC Cancer
cancer: a randomized controlled phase II a trial

15836

Nocturia in men is a chaotic condition dominated by nocturnal
polyuria

Int J Urol

22496-501 2015

Mod Pathol

28845-53

J Urol193 2123-30 2015

Hakimi A A, Tickoo S K, Jacobsen A, Sarungbam J,
Sfakianos J P, Sato Y, Morikawa T, Kume H, Fukayama M, TCEB1-mutated renal cell carcinoma: a distinct genomic and
12Homma Y, Chen Y B, Sankin A I, Mano R, Coleman J A, morphological subtype
Russo P, Ogawa S, Sander C, Hsieh J J, Reuter V E

2015

13

Ito H, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Homma Long-term caloric restriction in rats may prevent age related
Y, Kubota Y, Ito M, Andersson K E, Igawa Y
impairment of in vitro bladder function

14

PlGF-induced VEGFR1-dependent vascular remodeling
Iwamoto H, Zhang Y, Seki T, Yang Y, Nakamura M, Wang
determines opposing antitumor effects and drug resistance to Dll4- Sci Adv
J, Yang X, Torimura T, Cao Y.
Notch inhibitors.

1e1400244 2015

15Jensen LD, Nakamura M, Bräutigam L, Li X, Liu Y,
Samani NJ, Cao Y.

112

E594453

VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable Proc Natl Acadfor vascular and neuronal development in zebrafish.
Sci U S A

2015

Combination of docetaxel, ifosfamide and cisplatin (DIP) as a
Kakutani S, Fukuhara H, Taguchi S, Nagata M, Niimi A,
16 Hattori M, Miyazaki H, Fujimura T, Nakagawa T, Kume H, potential salvage chemotherapy for metastatic urothelial
carcinomaIgawa Y, Homma Y

Jpn J Clin Oncol

45281-5

2015

Int J Urol

22956-61

2015

13e107-12 2015

Int J Urol

22S1-7Hypertensive crisis during hemostasis of adrenal bleeding using aInt J Urolsoft-coagulation device.

22799-800 2015

Kume H, Kawai T, Nagata M, Azuma T, Miyazaki H,
21 Suzuki M, Fujimura T, Nakagawa T, Fukuhara H, Homma
YIntermittent docetaxel chemotherapy is feasible for castrationresistant prostate cancer

Mol Clin Oncol

3303-7Maeda D, Akiyama Y, Morikawa T, Kunita A, Ota Y,
22 Katoh H, Niimi A, Nomiya A, Ishikawa S, Goto A, Igawa
Y, Fukayama M, Homma Y

Hunner-Type (Classic) Interstitial Cystitis: A Distinct
Inflammatory Disorder Characterized by Pancystitis, withFrequent Expansion of Clonal B-Cells and Epithelial Denudation

PLoS One

10e014331
2015
6

Squamous differentiation and prognosis in upper urinary tract
urothelial carcinoma

Int J Clin Exp
Pathol87203-917Kamei J, Furuta A, Akiyama Y, Niimi A, Ichihara K,Fujimura T, Fukuhara H, Kume H, Homma Y, Igawa YKanatani A, Nakagawa T, Kawai T, Naito A, Sato Y,Yoshida K, Nozaki K, Nagata M, Yamada Y, Azuma T,18Suzuki M, Fujimura T, Fukuhara H, Nishimatsu H, KumeH, Igawa Y, Homma Y

Video-urodynamic effects of mirabegron, a beta3 -adrenoceptor
agonist, in patients with low-compliance bladder

Adjuvant chemotherapy is possibly beneficial for locally advanced Clin Genitourin
or node-positive bladder cancer
CancerClinicopathological characteristics and oncological outcomes inKanayama H O, Fukumori T, Fujimoto H, Nakanishi H,patients with renal cell carcinoma registered in 2007: The first
19 Ohyama C, Suzuki K, Nishiyama H, Eto M, Miki T, Kamoi
large-scale multicenter study from the Cancer Registration
K, Kubota Y, Takahashi S, Homma Y, Naito S
Committee of the Japanese Urological Association

20

23

Kawai T, Suzuki M, Otsuka M, Nakazono S, Tanaka Y,Homma Y

Makise N, Morikawa T, Kawai T, Nakagawa T, Kume H,
Homma Y, Fukayama M

201520152015

24 Matsumoto S, Matsumoto S, Homma Y

Measurement of oxyhemoglobin concentration changes ininterstitial cystitis female patients: A near-infrared spectroscopy
study

Int J Urol

22689-93

2015

3625

Nakajima Y, Osakabe A, Waku T, Suzuki T, Akaogi K,Fujimura T, Homma Y, Inoue S, Yanagisawa J

Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growththrough the Estrogen Receptor beta-KLF5 Pathway

Mol Cell Biol

144-562015

26

Nakamura M, Satoh N, Suzuki M, Kume H, Homma Y,
Seki G, Horita S

Stimulatory effect of insulin on renal proximal tubule sodiumtransport is preserved in type 2 diabetes with nephropathy

Biochem Biophys
461 154-8Res Commun2015Nakamura M, Yamazaki O, Shirai A, Horita S, Satoh N,
27 Suzuki M, Hamasaki Y, Noiri E, Kume H, Enomoto Y,Homma Y, Seki G

Preserved Na/HCO3 cotransporter sensitivity to insulin may
promote hypertension in metabolic syndrome

Kidney Int

535-422015

Epub2015

87

28

Niimi A, Nomiya A, Yamada Y, Suzuki M, Fujimura T,Fukuhara H, Kume H, Igawa Y, Homma Y

Hydrodistension with or without fulguration of hunner lesions for
Neurourol Urodyninterstitial cystitis: Long-term outcomes and prognostic predictors

29Nishimatsu H, Suzuki E, Saito Y, Niimi A, Nomiya A,Fukuhara H, Kume H, Homma Y

Senescent Cells Impair Erectile Function through Induction ofEndothelial Dysfunction and Nerve Injury in Mice

PLoS One

10e012412
2015
930

Nishimatsu H, Suzuki E, Saito Y, Niimi A, Nomiya A,Yamada D, Homma Y

Neuromedin B Restores Erectile Function by Protecting theCavernous Body and the Nitrergic Nerves from Injury in a
Diabetic Rat Model

PLoS One

10e013387
2015
4J Endourol

29770-6

Perioperative Outcome Comparisons Between Open andSugihara T, Yasunaga H, Yu C, Horiguchi H, Nishimatsu H,
Laparoscopic Nephroureterectomy Among a Population-Based
31
Fushimi K, Kattan M W, Homma Y
Cohort from 2010 to 20122015

Synergic Suppressive Effect of Silodosin and Imidafenacin on
Non-Voiding Bladder Contractions in Male Rats with Subacute
Bladder Outlet Obstruction.

32

Sugiyama R, Aizawa N, Ito H, Fujimura T, Suzuki M,
Nakagawa T, Fukuhara H, Kume H, Homma Y, Igawa Y.

33

Impact of adjuvant chemotherapy on patients with pathological
Tabata M, Ikeda M, Urakami S, Takahashi S, Sakaguchi K,
stage T3b and/or lymph node metastatic bladder cancer after
Kurosawa K, Okaneya T.
radical cystectomy.

LUTSEpub2015

2015

Jpn J Clin Oncol

45963-7

Radical Prostatectomy versus External Beam Radiotherapy for
cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes
Including Mortality

PLoS One

10e014112
2015
3Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Kawai
Pretreatment neutrophil-to-lymphocyte ratio as an independentT, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose
predictor of survival in patients with metastatic urothelial
35Y, Sato T, Ishikawa A, Uemura Y, Fujimura T, Fukuhara H,carcinoma: A multi-institutional study
Kume H, Homma Y

Int J Urol

22638-43

2015

Takahashi M, Kume H, Koyama K, Nakagawa T, Fujimura
Preoperative Evaluation of Renal Cell Carcinoma by Using 18F36 T, Morikawa T, Fukayama M, Homma Y, Ohtomo K,
FDG PET/CT
Momose T

Clin Nucl Med

40936-40

2015

Taguchi S, Fukuhara H, Shiraishi K, Nakagawa K,
34 Morikawa T, Kakutani S, Takeshima Y, Miyazaki H,Fujimura T, Nakagawa T, Kume H, Homma Y

37

Takahashi S, Shiraishi T, Miles N, Trock BJ, Kulkarni P,Getzenberg RH

Nanowire analysis of cancer-testis antigens as biomarkers ofaggressive prostate cancer.

Urology

85704.e1-7 2015

38

Takahashi S, Aruga S, Yamamoto Y, Matsumoto T,Kitamura T, Homma Y.

Urinary Oxalate Excretion Decreased in Androgen ReceptorKnockout Mice by Suppressing Oxalate Synthesis in The Liver.

Open Journal ofUrology

5123-132 201539

Takayama K, Misawa A, Suzuki T, Takagi K, HayashizakiY, Fujimura T, Homma Y, Takahashi S, Urano T, Inoue S

Corrigendum: TET2 repression by androgen hormone regulates
Nat Commun
global hydroxymethylation status and prostate cancer progression

68219

2015

40

Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Urano T,Takahashi S, Homma Y, Aburatani H, Inoue S

RUNX1, an androgen- and EZH2-regulated gene, has differential
Oncotarget
roles in AR-dependent and -independent prostate cancer

62263-76 2015

41

Wang J, Cao Z, Zhang XM, Nakamura M, Sun M, Hartman Novel mechanism of macrophage-mediated metastasis revealed inCancer Res
J, Harris RA, Sun Y, Cao Y.
a zebrafish model of tumor development.

75306-15

2015

42Yamada Y, Nomiya A, Niimi A, Igawa Y, Ito T, Tomoe H,A survey on clinical practice of interstitial cystitis in Japan
Takei M, Ueda T, Homma Y

4486-902015

Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Safety and efficacy of mirabegron as 'add-on' therapy in patients
43 Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, with overactive bladder treated with solifenacin: a post-marketing, BJU Int
open-label study in Japan (MILAI study)
Okitsu A, Hamada T, Kobayashi A, Kuroishi K

116 612-22

2015

Efficacy and Safety of the Selective β3 -Adrenoceptor Agonist
Yamaguchi O, Marui E, Igawa Y, Takeda M, Nishizawa O, Mirabegron in Japanese Patients with Overactive Bladder: A
44
Randomized, Double-Blind, Placebo-Controlled, Dose-Finding
Ikeda Y, Ohkawa S.
Study.

784-92

20154363-702015

45Transl AndrolUrolLow Urin Tract
Symptoms

Zaitsu M, Toyokawa S, Tonooka A, Nakamura F, Takeuchi Sex differences in bladder cancer pathology and survival: analysis
Cancer MedT, Homma Y, Kobayashi Yof a population-based cancer registry（2）英文総説
No. Author

Title

JournalVol. PageYear

1

Adipose tissue-derived stem cells as a therapeutic tool for
cardiovascular disease.

World J Cardiol

26

2015

Suzuki E, Fujita D, Takahashi M, Oba S, Nishimatsu H.

454-65

2

Fukuhara H, Todo T.

New generation of oncolytic herpes virus.

Current Cancer
11Therapy Reviews

163-177 2015

3

Yokoyama O, Igawa Y, Takeda M, Yamaguchi T,Murakami M, Viktrup L.

Tadalafil for lower urinary tract symptoms secondary to benign
prostatic hyperplasia: a review of clinical data in Asian men andan update on the mechanism of action.

Ther Adv Urol

249-644Michel M, Igawa Y.

Therapeutic targets for overactive bladder other than smoothmuscle.

Exper Opin Ther
5
Targets

Title

JournalVol. Page

Year

221167-9

2015

564082

2015

52015

687-705 2015（3）英文症例報告
No. Author
1

Maekawa S, Nagata M, Watanabe H, Nozaki K, Takahashi
A, Minowada S, Homma Y

Resection of bulky chromophobe renal cell carcinoma resolved
severe idiopathic thrombocytopenic purpura: A case report

Int J Urol

2

Makino K, Kume H, Morikawa T, Niimi A, Fujimura T,
Nakagawa T, Fukuhara H, Homma Y

Adenocarcinoma at Anastomotic Site of Ureterosigmoidostomy
Potentially of Urothelial Origin Spreading to the Upper Urinary
Tract

Case Rep Urol

3

Urinary bladder urothelial carcinoma with concurrent
Makise N, Morikawa T, Takeshima Y, Fujimura T, Homma
plasmacytoid and micropapillary differentiations: A report of two Pathol Int
Y, Fukayama M.
cases with an emphasis on serum carbohydrate antigen 19-965495-500 2015

4Miyama Y, Morikawa T, Nakagawa T, Homma Y,Fukayama M

8515-9Lipid Cell and Micropapillary Variants of Urothelial Carcinoma of
Case Rep Oncol
the Ureter2015

5Otsuka M, Nagata M, Suzuki M, Nannya Y, Ota S,Tanimoto T, Kume H, Kurokawa M, Homma Y

6Primary Retroperitoneal Tumor with Unexpected Gingival
Involvement

Intern Med

54

1787-90 2015

Taguchi S, Kishida Y, Tamura K, Nose Y, Sato T, Ishikawa Intrapelvic Bulky Tumor as an Unusual Presentation of ErdheimA, Homma Y, Yamakawa M
Chester DiseaseIntern Med543241-5

2015

7

Invasive urothelial carcinoma with chordoid features may be an
Tajima S, Suzuki T, Yamada Y, Morikawa T, Minagawa D,ominous sign predicting sarcomatoid change: a case report of aHomma Y, Fukayama M
bladder carcinoma

Med MolMorphol

Epub

2015

8Yamamoto S, Yoshida K, Tsumura K, Nomiya A, Yoda K,
Xanthogranulomatous cystitis treated by transurethral resection.
Iida K, Homma Y, Enomoto Y.

Urol Case Rep

143-5

20153